The Dharma, sutras, and commentarial interpretations of interest to American Buddhists of all traditions with news that not only informs but transforms. Emphasis on meditation, enlightenment, karma, social evolution, and nonharming.
(To contact us, leave a comment marked "private").
Tuesday, January 18, 2022
Big Pharma owns the media (TJDS)
No, 270 “doctors” didn't criticize Joe Rogan or anything he said about Covid recovery on his podcast
FDA corruption way worse than thought
(The Jimmy Dore Show, 12/23/21) It's called "regulatory capture," and even cynics would be shocked at the level of corruption running rampant at the United States' FDA (Food and Drug Administration). Did you know that Big Pharma funds 75% of the drug approval research that goes on at the FDA and in return for those hundreds of millions of dollars can get "expedited" service? There's a revolving door between the FDA and large pharmaceutical concerns spins like an out-of-control merry-go-round. It all adds up to a regulatory system built to benefit rather than regulate Big Pharma at a major cost to ordinary American citizens -- both in terms of taxes and healthcare outcomes. Comedians Jimmy Dore and Kurt Metzger discuss this incredibly corrupt relationship between the FDA and Big Pharma.
All materials on this site are submitted by editors and readers. All images, unless otherwise noted, were taken from the Internet and are assumed to be in the public domain.
In the event that there is still a problem, issue, or error with copyrighted material, the break of the copyright is unintentional and noncommercial, and the material will be removed immediately upon presented proof.
Contact us by submitting a comment marked "private."
Do not follow this journal if you are under vinaya or parental restrictions. Secure protection by Sucuri.
Wisdom Quarterly: American Buddhist Journal is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 United States License. Permissions beyond the scope of this license may be available at creativecommons.org/about/licenses.
No comments:
Post a Comment